Mercer Global Advisors Inc Supernus Pharmaceuticals, Inc. Transaction History
Mercer Global Advisors Inc
- $43 Billion
- Q1 2025
A detailed history of Mercer Global Advisors Inc transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 10,114 shares of SUPN stock, worth $339,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,114
Previous 10,179
0.64%
Holding current value
$339,628
Previous $368,000
10.05%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SUPN
# of Institutions
301Shares Held
60.7MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$349 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$207 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$174 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$97.5 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$90.7 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.8B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...